Abstract
A positive family history is consistently reported as a risk factor for gastric cancer (GC), but the molecular basis for the familial aggregation is largely unknown. The risk associated with having one first-degree relative (FDR) with GC is approximately 1.3–3.5 fold increased. Hereditary cancer syndromes have been relatively well characterised, but their rarity largely precludes the development of trials of surveillance. In hereditary diffuse gastric cancer (HDGC), patients have a CDH1 mutation that results in a high penetrance of GC meaning that prophylactic gastrectomy is recommended, although this treatment results in significant psychosocial issues. The management of HDGC patients includes endoscopic surveillance, surgery and histological interpretation which require a high degree of selective expertise. Much of the remaining heritable risk of GC may be accounted for by low- and intermediate-penetrant genetic factors, i.e. common and rare variants, respectively. The advent of new methods such as next-generation sequencing has revealed a number of new candidate gene loci.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barber M, Murral A, Ito Y et al (2008) Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol 216(3):295–306
Beggs AD, Latchford AR et al (2010) Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 59:975–986
Blair V, Martin I, Shaw D et al (2006) Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol 4(3):262–275
Burn J et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from CAPP2 randomised controlled trial. Lancet 378:2081–2087
Cairns SR et al (2010) BSG guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 59:666–690
Cancer research UK (2015) http://www.cancerresearchuk.org/cancerinfo/cancerstats/types/stomach/incidence/. Accessed July 2015
Carneiro F, Charlton A, Huntsman D (2012) Hereditary diffuse gastric cancer. In: Bosman FT (ed) WHO classification of tumours of the digestive system. 4th edn: IARC
Ferlay J (2012) GLOBOCAN 2012 v1.0 cancer incidence and mortality worldwide. IARC CancerBase
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374–1403
Hillier SH, Fielder H (2009) Screening for stomach cancer: a report for the National Screening Committee. Accessed July 2015. http://legacy.screening.nhs.uk/policydb_download.php?doc=49
Hu B et al (2012) Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol 3(3):251–261
Kang HJ, Kim DH, Jeon TY et al (2010) Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic mucosal resection. Gastrointest Endosc 72(3):508–515
Koea JB, Karpeh MS, Brennan MF (2007) Gastric cancer in young patients: demographic, clinicopathological and prognostic factors in 92 patients. Ann Surg Oncol 7(5):346–351
Masciari S et al (2011) Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med 13:651–657
Norton JA, Ham CM, Van Dam J et al (2007) CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg 245(6):837–839
Pharoah PD, Guilford P et al (2001) Incidence of gastric and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121:1348–1353
The Cancer Genome Atlas (2015) http://cancergenome.nih.gov/newsevents/newsannouncements/TCGA_STAD_press_release_2014. Accessed July 2015
Tsubono Y, Hisamichi S (2000) Screening for gastric cancer in Japan. Gastric Cancer 3:9–18 (November 7)
van der Post RS, Vogelaar IP, Carneiro F et al (2015) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 52(6):361–74
Vasen HFA et al (1999) New clinical criteria for hereditary non-polyposis colorectal cancer. Gastroenterology 116(6):1453–1456
Worster E, Liu X et al (2014) The impact of prophylactic total gastrectomy on health related quality of life: a prospective cohort study. Ann Surg 464:673–679
Yaghoobi M et al (2010) Family history and the risk of gastric cancer. Br J Cancer, 102:237–242. http://www.nature.com/bjc/journal/v102/n2/full/6605380a.html
Zang ZJ et al (2012) Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodelling genes. Nat Genet 44:570–574
Acknowledgements
Prof. Rebecca Fitzgerald, Cambridge, kindly provided an advance copy of the updated international guidelines for the management of HDGC (Published online http://www.ncbi.nlm.nih.gov/pubmed/25979631).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Monahan, K.J., Hopkins, L. (2016). Diagnosis and Management of Hereditary Gastric Cancer. In: Pichert, G., Jacobs, C. (eds) Rare Hereditary Cancers. Recent Results in Cancer Research, vol 205. Springer, Cham. https://doi.org/10.1007/978-3-319-29998-3_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-29998-3_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29996-9
Online ISBN: 978-3-319-29998-3
eBook Packages: MedicineMedicine (R0)